These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36921035)

  • 1. Prior SARS-CoV-2 infection enhances and reshapes spike protein-specific memory induced by vaccination.
    Barateau V; Peyrot L; Saade C; Pozzetto B; Brengel-Pesce K; Elsensohn MH; Allatif O; Guibert N; Compagnon C; Mariano N; Chaix J; Djebali S; Fassier JB; Lina B; Lefsihane K; Espi M; Thaunat O; Marvel J; Rosa-Calatrava M; Pizzorno A; Maucort-Boulch D; Henaff L; Saadatian-Elahi M; Vanhems P; Paul S; Walzer T; Trouillet-Assant S; Defrance T
    Sci Transl Med; 2023 Mar; 15(687):eade0550. PubMed ID: 36921035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybrid Immunity Shifts the Fc-Effector Quality of SARS-CoV-2 mRNA Vaccine-Induced Immunity.
    Bowman KA; Stein D; Shin S; Ferbas KG; Tobin NH; Mann C; Fischinger S; Ollmann Saphire E; Lauffenburger D; Rimoin AW; Aldrovandi G; Alter G
    mBio; 2022 Oct; 13(5):e0164722. PubMed ID: 36000735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative kinetics of SARS-CoV-2 anti-spike protein RBD IgGs and neutralizing antibodies in convalescent and naïve recipients of the BNT162b2 mRNA vaccine versus COVID-19 patients.
    Trougakos IP; Terpos E; Zirou C; Sklirou AD; Apostolakou F; Gumeni S; Charitaki I; Papanagnou ED; Bagratuni T; Liacos CI; Scorilas A; Korompoki E; Papassotiriou I; Kastritis E; Dimopoulos MA
    BMC Med; 2021 Aug; 19(1):208. PubMed ID: 34420521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies.
    Mazzoni A; Vanni A; Spinicci M; Lamacchia G; Kiros ST; Rocca A; Capone M; Di Lauria N; Salvati L; Carnasciali A; Mantengoli E; Farahvachi P; Zammarchi L; Lagi F; Colao MG; Liotta F; Cosmi L; Maggi L; Bartoloni A; Rossolini GM; Annunziato F
    J Clin Invest; 2022 Mar; 132(6):. PubMed ID: 35139036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of neutralizing antibody responses after natural SARS-CoV-2 infection and vaccination in congolese individuals.
    Batchi-Bouyou AL; Djontu JC; Vouvoungui JC; Mfoutou Mapanguy CC; Lobaloba Ingoba L; Mougany JS; Boumpoutou KR; Diafouka-Kietela S; Ampa R; Ntoumi F
    BMC Infect Dis; 2022 Jul; 22(1):610. PubMed ID: 35831798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Profiling of In Vitro Reactivated Memory B Cells Following Natural SARS-CoV-2 Infection and Gam-COVID-Vac Vaccination.
    Astakhova EA; Byazrova MG; Yusubalieva GM; Kulemzin SV; Kruglova NA; Prilipov AG; Baklaushev VP; Gorchakov AA; Taranin AV; Filatov AV
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern.
    Wratil PR; Stern M; Priller A; Willmann A; Almanzar G; Vogel E; Feuerherd M; Cheng CC; Yazici S; Christa C; Jeske S; Lupoli G; Vogt T; Albanese M; Mejías-Pérez E; Bauernfried S; Graf N; Mijocevic H; Vu M; Tinnefeld K; Wettengel J; Hoffmann D; Muenchhoff M; Daechert C; Mairhofer H; Krebs S; Fingerle V; Graf A; Steininger P; Blum H; Hornung V; Liebl B; Überla K; Prelog M; Knolle P; Keppler OT; Protzer U
    Nat Med; 2022 Mar; 28(3):496-503. PubMed ID: 35090165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Immune Response to SARS-CoV-2 Vaccination: Insights Learned From Adult Patients With Common Variable Immune Deficiency.
    Quinti I; Locatelli F; Carsetti R
    Front Immunol; 2021; 12():815404. PubMed ID: 35126372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination.
    Mitsi E; Diniz MO; Reiné J; Collins AM; Robinson RE; Hyder-Wright A; Farrar M; Liatsikos K; Hamilton J; Onyema O; Urban BC; Solórzano C; Belij-Rammerstorfer S; Sheehan E; Lambe T; Draper SJ; Weiskopf D; Sette A; Maini MK; Ferreira DM
    Nat Commun; 2023 Oct; 14(1):6815. PubMed ID: 37884506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic T Cells Targeting Spike Glycoprotein Are Associated with Hybrid Immunity to SARS-CoV-2.
    Phan JM; Layton ED; Yu KKQ; Aguilar MS; Golez I; Franko NM; Logue JK; Rodda LB; Howard CA; Pepper M; Gale M; Chu HY; Seshadri C
    J Immunol; 2023 May; 210(9):1236-1246. PubMed ID: 36961450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immunity in dually vaccinated SARS-CoV-2-naïve individuals and in booster-vaccinated COVID-19-convalescent subjects.
    Glück V; Tydykov L; Mader AL; Warda AS; Bertok M; Weidlich T; Gottwald C; Köstler J; Salzberger B; Wagner R; Koller M; Gessner A; Schmidt B; Glück T; Peterhoff D
    Infection; 2022 Dec; 50(6):1475-1481. PubMed ID: 35403960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Prior Infection on SARS-CoV-2 Antibody Responses in Vaccinated Long-Term Care Facility Staff.
    Gallichotte EN; Nehring M; Stromberg S; Young MC; Snell A; Daniels J; Pabilonia KL; VandeWoude S; Ehrhart N; Ebel GD
    mSphere; 2022 Aug; 7(4):e0016922. PubMed ID: 35862798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 spike-reactive naïve B cells and pre-existing memory B cells contribute to antibody responses in unexposed individuals after vaccination.
    Teng S; Hu Y; Wang Y; Tang Y; Wu Q; Zheng X; Lu R; Pan D; Liu F; Xie T; Wu C; Li YP; Liu W; Qu X
    Front Immunol; 2024; 15():1355949. PubMed ID: 38420128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Spike Antibody Response to Natural Infection with SARS-CoV-2 and Its Activity against Emerging Variants.
    Chen CP; Huang KA; Shih SR; Lin YC; Cheng CY; Huang YC; Lin TY; Cheng SH
    Microbiol Spectr; 2022 Aug; 10(4):e0074322. PubMed ID: 35703556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of SARS-CoV-2 Viral Neutralizing Antibody Titers with Anti-Spike Antibodies and ACE-2 Inhibition among Vaccinated Individuals.
    Grunau B; Prusinkiewicz M; Asamoah-Boaheng M; Golding L; Lavoie PM; Petric M; Levett PN; Haig S; Barakauskas V; Karim ME; Jassem AN; Drews SJ; Sediqi S; Goldfarb DM
    Microbiol Spectr; 2022 Oct; 10(5):e0131522. PubMed ID: 36121252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Vaccine Induced Atypical Immune Responses in Antibody Defects: Everybody Does their Best.
    Salinas AF; Mortari EP; Terreri S; Quintarelli C; Pulvirenti F; Di Cecca S; Guercio M; Milito C; Bonanni L; Auria S; Romaggioli L; Cusano G; Albano C; Zaffina S; Perno CF; Spadaro G; Locatelli F; Carsetti R; Quinti I
    J Clin Immunol; 2021 Nov; 41(8):1709-1722. PubMed ID: 34669144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients.
    Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y
    Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose.
    Belik M; Liedes O; Vara S; Haveri A; Pöysti S; Kolehmainen P; Maljanen S; Huttunen M; Reinholm A; Lundberg R; Skön M; Österlund P; Melin M; Hänninen A; Hurme A; Ivaska L; Tähtinen PA; Lempainen J; Kakkola L; Jalkanen P; Julkunen I
    Front Immunol; 2023; 14():1099246. PubMed ID: 36756112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.